BAYLEY MCMICHAEL: Open Payments
NPI 1295498897 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 22 payments from 12 companies in 2025. Trend: 2023 $552 · 2024 $609 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| PFIZER INC. | 2 | $41 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Celltrion USA Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: RINVOQ, XIFAXAN, ENTYVIO, VELSIPITY, REZDIFFRA, VEGZELMA, DUPIXENT, Wegovy.
Industry payments across NC — which companies pay providers there.
